NCT04847986

Brief Summary

The pilot randomized controlled trial aims to assess effects of a guided online acceptance and commitment therapy (ACT) intervention on distressed family caregivers of people with dementia (PwD) compared to the control group. A total of 24 family caregivers of PwD who meet the inclusion criteria will be recruited and randomized to either the intervention or control group. Exploratory hypotheses are that the ACT group will show decreases in caregivers' psychological distress and burden and improvements in QoL and engagement in meaningful activities at posttest and 1-month follow-up, compared to the control group. Also, the project will evaluate the feasibility of recruitment, adherence, and retention of caregivers and explore caregivers' experiences in the ACT intervention through semi-structured interviews at posttest. As part of the pretest, we will also explore caregivers' perceived impacts of COVID-19 on daily lives.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
19

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

July 19, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2022

Completed
Last Updated

June 28, 2022

Status Verified

June 1, 2022

Enrollment Period

11 months

First QC Date

April 8, 2021

Last Update Submit

June 27, 2022

Conditions

Keywords

Acceptance and Commitment TherapyAlzheimer's DiseaseBurdenCaregiversDementiaMindfulnessPsychological healthQuality of lifeSelf-compassionStressDepressionAnxietyGuiltGrief

Outcome Measures

Primary Outcomes (2)

  • Change from baseline to immediately after the intervention and 1 month follow-up on the Depression, Anxiety and Stress Scale

    Depression, Anxiety and Stress Scale - 21 is a 21-item questionnaire assessing depressive symptoms, anxiety, and stress over the past 7 days on a scale of 0 to 3. Scores on the individual subscales range from 0 to 21. Higher scores indicate greater symptomatology in each subscale of depressive symptoms (7 items), anxiety (7 items), and stress (7 items).

    Change from baseline to immediately after the intervention and 1 month follow-up

  • Change from baseline to immediately after the intervention and 1 month follow-up on the Zarit Burden Interview

    Zarit Burden Interview is a 12-item self-report questionnaire assessing caregiver burden on a scale of 0 to 4. Higher scores indicate higher levels of burden. The total scores range from 0 to 48, and scores of 17 or greater indicate severe/high burden.

    Change from baseline to immediately after the intervention and 1 month follow-up

Secondary Outcomes (7)

  • Change from baseline to immediately after the intervention and 1 month follow-up on the World Health Organization Quality of Life-BREF - Psychological health component

    Change from baseline to immediately after the intervention and 1 month follow-up

  • Change from baseline to immediately after the intervention and 1 month follow-up on the Meuser Caregiver Grief Inventory

    Change from baseline to immediately after the intervention and 1 month follow-up

  • Change from baseline to immediately after the intervention and 1 month follow-up on the Caregiver Guilt Questionnaire

    Change from baseline to immediately after the intervention and 1 month follow-up

  • Change from baseline to immediately after the intervention and 1 month follow-up on the Self-Compassion Scale- Short Form

    Change from baseline to immediately after the intervention and 1 month follow-up

  • Change from baseline to immediately after the intervention and 1 month follow-up on the Action and Acceptance Questionnaire-II

    Change from baseline to immediately after the intervention and 1 month follow-up

  • +2 more secondary outcomes

Other Outcomes (2)

  • System Usability Scale

    immediately after the intervention

  • Interviews of participants

    at baseline and immediately after the intervention

Study Arms (2)

acceptance and commitment therapy (ACT) group

EXPERIMENTAL

8 weekly ACT sessions individually guided by a trained coach through Zoom videoconferencing with psychoeducation materials provided

Behavioral: acceptance and commitment therapy (ACT)

Control group

SHAM COMPARATOR

care as usual with psychoeducation materials provided

Behavioral: Control group

Interventions

Caregivers assigned to this intervention group will receive individual ACT sessions guided by a trained coach for one hour per week over 8 weeks through Zoom videoconferencing with psychoeducation materials provided.

acceptance and commitment therapy (ACT) group
Control groupBEHAVIORAL

The control group will receive care as usual with psychoeducation materials provided.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • community-dwelling adults (age 18 or over) who are currently taking the primary responsibility for the care of a relative with dementia living in the community
  • devoting at least four hours daily to the care of the relative with dementia
  • having at least mild symptoms of psychological distress as measured by the Depression, Anxiety and Stress Scale (DASS-21; Antony et al., 1988)
  • having a computer or a smartphone with the internet access at home and
  • being able to provide informed consent.

You may not qualify if:

  • having cognitive, physical, or sensory deficits or language barriers (non-English communicator) that impede study participation
  • currently receiving a psychological therapy
  • having a prior experience in ACT
  • having psychiatric hospitalizations or diagnoses of mental illness in the previous two years
  • taking antipsychotic or anticonvulsant medication at the time of recruitment
  • considering or planning to place family members of PwD in a nursing home within four months or
  • having the possibility of study dropouts due to other medical conditions of family members with dementia (e.g., conditions that may impede study participation due to frequent hospitalization or death)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

Related Publications (1)

  • Han A, Yuen HK, Jenkins J. The feasibility and preliminary effects of a pilot randomized controlled trial: Videoconferencing acceptance and commitment therapy in distressed family caregivers of people with dementia. J Health Psychol. 2023 May;28(6):554-567. doi: 10.1177/13591053221141131. Epub 2023 Jan 2.

MeSH Terms

Conditions

Alzheimer DiseaseDementiaPsychological Well-BeingDepressionAnxiety Disorders

Interventions

Acceptance and Commitment TherapyControl Groups

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersPersonal SatisfactionBehaviorBehavioral Symptoms

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Areum Han, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

April 8, 2021

First Posted

April 19, 2021

Study Start

July 19, 2021

Primary Completion

June 22, 2022

Study Completion

June 22, 2022

Last Updated

June 28, 2022

Record last verified: 2022-06

Data Sharing

IPD Sharing
Will not share

Locations